107 related articles for article (PubMed ID: 191374)
1. Demonstration of high levels of cytolytic antibodies reactive with HSV-1 and HSV-2 infected cell membranes in sera of genital tumour patients.
Roane PR; washington P
IARC Sci Publ (1971); 1975; (11 Pt 2):299-305. PubMed ID: 191374
[No Abstract] [Full Text] [Related]
2. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
Najem SN; Vestergaard BF; Potter CW
Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
[TBL] [Abstract][Full Text] [Related]
3. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay.
Jankowski MA; Petersen EE; Böcker JF
Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235
[TBL] [Abstract][Full Text] [Related]
4. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
[TBL] [Abstract][Full Text] [Related]
5. AG-4 complement-fixing antibodies in cervical cancer and herpes-infected patients using local herpes simplex virus type 2.
Arsenakis M; Georgiou GM; Welsh JK; Cauchi MN; May JT
Int J Cancer; 1980 Jan; 25(1):67-71. PubMed ID: 6249764
[TBL] [Abstract][Full Text] [Related]
6. [Neutralizing antibodies against type 2 herpes simplex virus in women with cervicouterine cancer].
Ruiz-Gómez J; Gallegos Vargas G; Carranza García J; Alvarez y Muñoz MT
Ginecol Obstet Mex; 1977 Dec; 42(254):369-75. PubMed ID: 233828
[No Abstract] [Full Text] [Related]
7. [Etiological role of the herpes simplex virus in causing cervical cancer].
Posevaia TA; Shubladze AK; Grigor'ev VV; Ugriumov EP; Kitsak VIa
Vopr Virusol; 1979; (6):611-5. PubMed ID: 230645
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
Christenson B; Espmark A
Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
[TBL] [Abstract][Full Text] [Related]
9. Infection with herpes-simplex viruses 1 and 2. II.
Nahmias AJ; Roizman B
N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
Sabin AB; Tarro G
Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
[TBL] [Abstract][Full Text] [Related]
11. Complement-dependent cytotoxic antibodies in the course of cervical carcinoma.
Christenson B
Int J Cancer; 1977 Nov; 20(5):694-701. PubMed ID: 200570
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
[No Abstract] [Full Text] [Related]
13. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
Subramanian T; Rawls WE
J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
Chiphangwi JD
IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
[TBL] [Abstract][Full Text] [Related]
15. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
[No Abstract] [Full Text] [Related]
16. Antigenic relationship between herpes simplex viruses, human cervical cancer and HSV-associated hamster tumours.
Nahmias AJ; Del Buono I
IARC Sci Publ (1971); 1975; (11 Pt 1):309-13. PubMed ID: 190133
[No Abstract] [Full Text] [Related]
17. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
[TBL] [Abstract][Full Text] [Related]
18. IgG-, IgA- and IgM-antibodies to herpes simplex virus type 2 in sera from patients with cancer of the uterine cervix.
El Falaky IH; Vestergaard BF
Eur J Cancer (1965); 1977 Mar; 13(3):247-51. PubMed ID: 193693
[No Abstract] [Full Text] [Related]
19. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
Fan J; Zeng Y; Liu YF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
[No Abstract] [Full Text] [Related]
20. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
